Combined treatment with anti-CD20 (rituximab) and CHOP in relapsed advanced-stage follicular lymphomas
| dc.contributor.author | Domingo Domènech, Eva | |
| dc.contributor.author | González Barca, Eva | |
| dc.contributor.author | Estany, Carla | |
| dc.contributor.author | Sureda, Anna | |
| dc.contributor.author | Besalduch, Joan | |
| dc.contributor.author | Fernández de Sevilla Ribosa, Alberto | |
| dc.date.accessioned | 2020-12-15T14:04:55Z | |
| dc.date.available | 2020-12-15T14:04:55Z | |
| dc.date.issued | 2002-11-01 | |
| dc.date.updated | 2020-12-15T14:04:56Z | |
| dc.description.abstract | We studied the safety and efficacy of combined treatment with rituximab plus CHOP in 16 patients with relapsed advanced-stage follicular lymphomas. The intent-to-treat overall response rate (ORR) was 88%, 75% complete remissions (CR) and 13% partial remissions (PR). At a median follow-up of 18 months, 63% of the patients are alive (50% CR). The combination of rituximab and CHOP in relapsed advanced-stage follicular lymphomas achieves high ORRs and CRs, with low toxicity except for in previously autografted patients. | |
| dc.format.extent | 2 p. | |
| dc.format.mimetype | application/pdf | |
| dc.identifier.idgrec | 519004 | |
| dc.identifier.issn | 0390-6078 | |
| dc.identifier.pmid | 12414357 | |
| dc.identifier.uri | https://hdl.handle.net/2445/172746 | |
| dc.language.iso | eng | |
| dc.publisher | Ferrata Storti Foundation | |
| dc.relation.isformatof | Reproducció del document publicat a: https://haematologica.org/issue/view/99 | |
| dc.relation.ispartof | Haematologica, 2002, vol. 87, num. 11, p. 1229-1230 | |
| dc.rights | (c) Ferrata Storti Foundation, 2002 | |
| dc.rights.accessRights | info:eu-repo/semantics/openAccess | |
| dc.source | Articles publicats en revistes (Ciències Clíniques) | |
| dc.subject.classification | Anticossos monoclonals | |
| dc.subject.classification | Ús terapèutic | |
| dc.subject.classification | Limfomes | |
| dc.subject.other | Monoclonal antibodies | |
| dc.subject.other | Therapeutic use | |
| dc.subject.other | Lymphomas | |
| dc.title | Combined treatment with anti-CD20 (rituximab) and CHOP in relapsed advanced-stage follicular lymphomas | |
| dc.type | info:eu-repo/semantics/article | |
| dc.type | info:eu-repo/semantics/publishedVersion |
Fitxers
Paquet original
1 - 1 de 1